Ligand Pharmaceuticals Inc (LGND)

Long-Term Debt

$1.13B

Quarterly · Period ending: · USD

LGND logo

LGND Long-Term Debt

Latest reported$1.13B
LGND Quarterly Long-Term Debt ($2.30M → $1.13B)
High-resolution chart · PNG

LGND long-term debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Long-Term Debt — Quarterly (USD)
Period endingLong-Term Debt (USD)
1,130,371,000
450,889,000
450,396,000
449,908,000
4,629,000
3,565,000
5,815,000
6,267,000
6,415,000
5,191,000
5,755,000
5,832,000
10,991,000
11,183,000
10,336,000
34,893,000
27,088,000
193,298,000
322,973,000
328,356,000
320,089,000
358,394,000
447,936,000
458,893,000
458,853,000
453,663,000
648,929,000
641,465,000
634,698,000
621,307,000
609,864,000
602,839,000
595,912,000
16,078,000
18,859,000
21,597,000
24,293,000
26,948,000
29,563,000
32,138,000
0
204,653,000
205,372,000
202,951,000
200,567,000
198,219,000
195,908,000
193,631,000
0
0
0
3,725,000
1,970,000
5,494,000
13,443,000
24,410,000
39,388,000
34,151,000
20,286,000
49,987,000
29,975,000
30,577,000
22,851,000
28,618,000
29,386,000
34,341,000
36,274,000
45,374,000
46,171,000
46,860,000
49,702,000
172,000
266,000
403,000
627,000
889,000
1,259,000
1,641,000
2,156,000
142,070,000
142,314,000
143,804,000
170,175,000
170,195,000
170,829,000
171,115,000
171,092,000
171,258,000
170,803,000
170,846,000
170,052,000
157,932,000
158,653,000
158,957,000
155,250,000
7,051,000
2,640,000
2,879,000
136,758,000
137,061,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.